Literature DB >> 7261069

Mechanisms in the in vivo release of lymphokines. V. Responses in alloxan-treated and genetically diabetic mice.

K L Pasko, S B Salvin, A Winkelstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7261069     DOI： 10.1016/0008-8749(81)90314-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  5 in total

Review 1.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

2.  Alterations in immunological reactivity in encephalomyocarditis virus-induced murine diabetes. I. Defective primary IgM plaque forming cell responses to sheep erythrocytes: correction by islet cell transplantation.

Authors:  B S Handwerger; G Fernandes; T Riehm; J W Yoon; D E Sutherland; D M Brown
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Resistance and susceptibility to infection in inbred murine strains. III. Effect of thymosin on cellular immune responses of alloxan diabetic mice.

Authors:  S B Salvin; E P Tanner
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

4.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Altered immune function in alloxan-induced diabetes in mice.

Authors:  E J Glass; J Stewart; D M Weir
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.